<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl1">
 <label>Table 1</label>
 <caption>
  <p>Comparison of characteristics and follow-up of patients admitted at Necker Hospital (Paris, France) between October 2018 and February 2019 and presenting with community-acquired versus nosocomial RSV-associated ALRI</p>
 </caption>
 <alt-text id="alttext0010">Table 1</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th/>
    <th align="char">Total (n = 240)</th>
    <th align="char">Patients with community acquired RSV-associated ALRI (n = 229)</th>
    <th align="char">Patients with nosocomial RSV-associated ALRI (n = 11)</th>
    <th>
     <italic>p</italic>
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>Male sex (n, %)</td>
    <td>113 (47.1)</td>
    <td>107 (46.7)</td>
    <td>6 (54.5)</td>
    <td align="char">0.61</td>
   </tr>
   <tr>
    <td>
     <bold>Age (n, %)</bold>
    </td>
    <td/>
    <td/>
    <td/>
    <td align="char">0.0005</td>
   </tr>
   <tr>
    <td>0–5 months</td>
    <td>141 (58.8)</td>
    <td>138 (60.3)</td>
    <td>3 (27.3)</td>
    <td/>
   </tr>
   <tr>
    <td>
     <italic>including children born between 32 and 36 WOG</italic>
    </td>
    <td>
     <italic>23</italic>
    </td>
    <td>
     <italic>23</italic>
    </td>
    <td>
     <italic>0</italic>
    </td>
    <td/>
   </tr>
   <tr>
    <td align="char">
     <italic>including children born &lt;</italic> 
     <italic>32 WOG</italic>
    </td>
    <td>
     <italic>3</italic>
    </td>
    <td>
     <italic>3</italic>
    </td>
    <td>
     <italic>0</italic>
    </td>
    <td/>
   </tr>
   <tr>
    <td>6–11 months</td>
    <td>28 (11.7)</td>
    <td>27 (11.8)</td>
    <td>1 (9.1)</td>
    <td/>
   </tr>
   <tr>
    <td>12–23 months</td>
    <td>23 (9.6)</td>
    <td>23 (10.0)</td>
    <td>0 (0.0)</td>
    <td/>
   </tr>
   <tr>
    <td>2–17 years</td>
    <td>37 (15.4)</td>
    <td>35 (15.3)</td>
    <td>2 (18.2)</td>
    <td/>
   </tr>
   <tr>
    <td>18–59 years</td>
    <td>4 (1.7)</td>
    <td>4 (1.7)</td>
    <td>0 (0.0)</td>
    <td/>
   </tr>
   <tr>
    <td>≥ 60 years</td>
    <td>7 (2.9)</td>
    <td>2 (0.9)</td>
    <td>5 (45.5)</td>
    <td/>
   </tr>
   <tr>
    <td colspan="5">
     <bold>Underlying medical conditions (n, %)</bold>
    </td>
   </tr>
   <tr>
    <td>At least one CCC</td>
    <td>105 (43.8)</td>
    <td>94 (41.0)</td>
    <td>11 (100.0)</td>
    <td align="char">&lt;0.0001</td>
   </tr>
   <tr>
    <td>
     <italic>Neuromuscular CCC</italic>
    </td>
    <td>
     <italic>15 (6.3)</italic>
    </td>
    <td>
     <italic>13 (5.7)</italic>
    </td>
    <td>
     <italic>2 (18.2)</italic>
    </td>
    <td/>
   </tr>
   <tr>
    <td>
     <italic>Cardiovascular CCC</italic>
    </td>
    <td>
     <italic>24 (10.0)</italic>
    </td>
    <td>
     <italic>21 (9.2)</italic>
    </td>
    <td>
     <italic>3 (27.3)</italic>
    </td>
    <td/>
   </tr>
   <tr>
    <td>
     <italic>Respiratory CCC</italic>
    </td>
    <td>
     <italic>52 (21.7)</italic>
    </td>
    <td>
     <italic>48 (21.0)</italic>
    </td>
    <td>
     <italic>4 (36.4)</italic>
    </td>
    <td/>
   </tr>
   <tr>
    <td>
     <italic>Renal CCC</italic>
    </td>
    <td>
     <italic>11 (4.6)</italic>
    </td>
    <td>
     <italic>7 (3.1)</italic>
    </td>
    <td>
     <italic>4 (36.4)</italic>
    </td>
    <td/>
   </tr>
   <tr>
    <td>
     <italic>Gastrointestinal CCC</italic>
    </td>
    <td>
     <italic>7 (2.9)</italic>
    </td>
    <td>
     <italic>6 (2.6)</italic>
    </td>
    <td>
     <italic>1 (9.1)</italic>
    </td>
    <td/>
   </tr>
   <tr>
    <td>
     <italic>Hematological CCC and/or immune deficiency</italic>
    </td>
    <td>
     <italic>24 (10.0)</italic>
    </td>
    <td>
     <italic>18 (7.9)</italic>
    </td>
    <td>
     <italic>6 (54.5)</italic>
    </td>
    <td/>
   </tr>
   <tr>
    <td>
     <italic>Metabolic CCC</italic>
    </td>
    <td>
     <italic>2 (0.8)</italic>
    </td>
    <td>
     <italic>2 (0.9)</italic>
    </td>
    <td>
     <italic>0 (0.0)</italic>
    </td>
    <td/>
   </tr>
   <tr>
    <td>
     <italic>Other congenital or genetic defect</italic>
    </td>
    <td>
     <italic>22 (9.2)</italic>
    </td>
    <td>
     <italic>21 (9.2)</italic>
    </td>
    <td>
     <italic>1 (9.1)</italic>
    </td>
    <td/>
   </tr>
   <tr>
    <td colspan="5">
     <bold>Antiviral prophylaxis (n, %)</bold>
    </td>
   </tr>
   <tr>
    <td>palivizumab</td>
    <td>6 (2.5)</td>
    <td>6 (2.6)</td>
    <td>0 (0.0)</td>
    <td align="char">1.0</td>
   </tr>
   <tr>
    <td>i.v. or s.c. polyvalent immunoglobulin</td>
    <td>3 (1.3)</td>
    <td>3 (1.3)</td>
    <td>0 (0.0)</td>
    <td align="char">1.0</td>
   </tr>
   <tr>
    <td colspan="5">
     <bold>Viral co-/super-infection (n, %)</bold>
    </td>
   </tr>
   <tr>
    <td>At least one virus</td>
    <td>42 (17.5)</td>
    <td>40 (17.5)</td>
    <td>2 (18.2)</td>
    <td align="char">1.0</td>
   </tr>
   <tr>
    <td>
     <italic>influenza virus</italic>
    </td>
    <td>
     <italic>4</italic>
    </td>
    <td>
     <italic>3</italic>
    </td>
    <td>
     <italic>1</italic>
    </td>
    <td/>
   </tr>
   <tr>
    <td>
     <italic>parainfluenza virus</italic>
    </td>
    <td>
     <italic>3</italic>
    </td>
    <td>
     <italic>3</italic>
    </td>
    <td>
     <italic>0</italic>
    </td>
    <td/>
   </tr>
   <tr>
    <td>
     <italic>rhinovirus</italic>
    </td>
    <td>
     <italic>24</italic>
    </td>
    <td>
     <italic>23</italic>
    </td>
    <td>
     <italic>1</italic>
    </td>
    <td/>
   </tr>
   <tr>
    <td>
     <italic>adenovirus</italic>
    </td>
    <td>
     <italic>4</italic>
    </td>
    <td>
     <italic>4</italic>
    </td>
    <td>
     <italic>0</italic>
    </td>
    <td/>
   </tr>
   <tr>
    <td>
     <italic>human metapneumovirus</italic>
    </td>
    <td>
     <italic>1</italic>
    </td>
    <td>
     <italic>1</italic>
    </td>
    <td>
     <italic>0</italic>
    </td>
    <td/>
   </tr>
   <tr>
    <td>
     <italic>coronavirus</italic>
    </td>
    <td>
     <italic>11</italic>
    </td>
    <td>
     <italic>10</italic>
    </td>
    <td>
     <italic>1</italic>
    </td>
    <td/>
   </tr>
   <tr>
    <td colspan="5">
     <bold>Bacterial lower respiratory tract co-/super-infection</bold>
    </td>
   </tr>
   <tr>
    <td>Microbiologically proven infection</td>
    <td>14 (5.8)</td>
    <td>13 (5.7)</td>
    <td>1 (9.1)</td>
    <td align="char">0.49</td>
   </tr>
   <tr>
    <td>Suspected infection</td>
    <td>67 (27.9)</td>
    <td>64 (27.9)</td>
    <td>3 (27.3)</td>
    <td align="char">1.0</td>
   </tr>
   <tr>
    <td colspan="5">
     <bold>Clinical follow-up</bold>
    </td>
   </tr>
   <tr>
    <td>LOS (days) (median, IQR)</td>
    <td>7 [5–10]</td>
    <td>7 [5–9]</td>
    <td>17 [11–26]
     <xref rid="tbl1fna" ref-type="table-fn">a</xref>
    </td>
    <td align="char">&lt; 0.0001</td>
   </tr>
   <tr>
    <td>ICU admission (n, %)</td>
    <td>97 (40.4)</td>
    <td>94 (41.0)</td>
    <td>3 (27.3)</td>
    <td align="char">0.53</td>
   </tr>
   <tr>
    <td>Oxygen requirement (n, %)</td>
    <td>189 (78.8)</td>
    <td>182 (79.5)</td>
    <td>7 (63.6)</td>
    <td align="char">0.25</td>
   </tr>
   <tr>
    <td>Mechanical ventilation requirement (n, %)</td>
    <td>9 (3.8)</td>
    <td>8 (3.5)</td>
    <td>1 (9.1)</td>
    <td align="char">0.35</td>
   </tr>
   <tr>
    <td>Non-invasive ventilation and/or high-flow nasal oxygen requirement (n, %)</td>
    <td>73 (30.4)</td>
    <td>72 (31.4)</td>
    <td>1 (9.1)</td>
    <td align="char">0.18</td>
   </tr>
   <tr>
    <td>Antibiotic treatment (n, %)</td>
    <td>142 (59.2)</td>
    <td>137 (59.8)</td>
    <td>5 (45.5)</td>
    <td align="char">0.36</td>
   </tr>
   <tr>
    <td>Death (n, %)</td>
    <td>3 (1.3)</td>
    <td>3 (1.3)</td>
    <td>0 (0.0)</td>
    <td align="char">1.0</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>RSV = respiratory syncytial virus; ALRI = acute lower respiratory tract infection; WOG = weeks of gestation; CCC = chronic complex conditions; i.v. = intraveinous; s.c. = subcutaneous; LOS = length of stay; ICU = intensive care unit.</p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tbl1fna">
   <label>a</label>
   <p id="ntpara0010">For healthcare-associated infections, the length of stay after the diagnosis of RSV ALRI was described.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
